Health Idea Now
Tuesday, 19 February 2019
Merck's Keytruda fails late-stage study in liver cancer patients
Merck & Co Inc said on Tuesday its cancer drug Keytruda failed the main goals of a late-stage trial and did not extend life of patients with a type of liver cancer.
from Reuters: Health News https://reut.rs/2XlrTWi
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment